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1???????????????????????????? ?????? ????? ?? ??????? 
Prostate Artery Embolization (PAE) is a technically demanding new treatment option 
for Benign Prostatic Hyperplasia (BPH). We present a case of radiation-induced 
dermitis in a 63-year-old patient after a technically successful PAE, due to high 
radiation exposure and long procedural time. Anatomical and technical aspects are 
discussed, as well as recommendations to decrease radiation exposure in these 
procedures. 
Keywords 
Prostatic artery embolization, benign prostatic hyperplasia, radiation exposure, 
radiodermitis, complications. 
INTRODUCTION 
Recently, PAE has been adopted for the treatment of low-urinary tract symptoms 
(LUTS) due to BPH. Previous studies have established PAE as a safe and effective 
treatment, associated with reduction in prostate volume, significant symptom 
reduction, and improvement of functional and clinical outcomes (1-3). However, PAE 
requires a well-trained interventional radiologist because of the complex prostatic 
vascular anatomy and the potential for complications in elderly patients with 
atherosclerosis, very thin prostatic arteries and comorbidities. Moreover, these features 
can lead to major radiation exposure during the procedure. 
To authors’ knowledge, no case of radiation exposure complication has been 
reported so far in this type of procedure. Herein, we describe a case of radiodermitis 
following a technically successful PAE and discuss specific aspects related. 
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Radiodermitis after prostatic artery embolization. Case report and review of the literature
2CASE REPORT 
A 63-year-old man with multiple comorbidities including non-ST segment 
elevation acute coronary syndrome (NSTE-ACS), sleep apnea/hypopnea syndrome 
(SAHS) in treatment with continuous positive airway pressure (CPAP) and morbid 
obesity (body mass index 44.1 Kg/m2) underwent PAE for treatment of LUTS due to 
BPH. His symptoms were classified as moderate according to the International Prostate 
Symptom Score (IPSS 19), being manifested as increased urinary frequency, nycturia, 
urgency, incontinence and weak urine stream, all of them refractory to optimized 
medical treatment (selective α-blockers and 5α-reductase inhibitors). Of note, patient 
had negative histopathology reports by various US-guided and CT-guided biopsies 
despite persisting high serum prostate specific antigen (PSA) levels during the last 15 
years. Patient’s preembolization serum PSA level was 13.7 ng/mL (reference range 0–4 
ng/mL). The prostate volume was 230 cm3 as determined by transabdominal US and 
243 cm3 as determined by CT. Urodynamic study revealed maximum flow rate (Qmax) 
of 11 mL/s, postvoid residual volume of 294 mL and voided urinary volume of 98 mL. 
After multidisciplinary decision, patient underwent PAE procedure according to 
previously described methods (4,5), after informed consent was obtained. PAE was 
performed in. the interventional radiology suite (Allura Xper FD20, Philips Medical 
Systems, Nederland B.V., Holland) with nonionic contrast medium (Optiray Ultraject 
320 mg/mL. Mallinckrodt Spain S.L, Spain). A Foley catheter was inserted, and its 
balloon inflated with contrast solution, and patient received a single 400 mg 
intravenous dose of ciprofloxacin. After digital subtraction angiographies (DSA) from 
both internal iliac arteries, selective catheterization of the right and left inferior vesical 
arteries (IVA) was performed using a microcatheter (Progreat 2.0. Terumo, Japan), 
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3which was especially difficult due to atherosclerosis (Figure 1). An important 
anastomosis between the left prostatic lobe artery and the dorsal penile artery was then 
identified, and selective occlusion with a platinum microcoil was performed (Axium 
detachable coil system. Ev3 Micro Therapeutics, Inc, USA) in order to avoid non-target 
embolization (Figure 2). After that, we embolized bilaterally to total stasis with 300-500 
μm Embosphere® Microspheres (Biosphere Medical, Roissy, France), avoiding reflux of 
embolic agent to undesired arteries. 
Procedure lasted 310 minutes, with 72 minutes of total fluoroscopy time. 
Measurements of radiation exposure demonstrated a Kerma-area-product of 8023949 
mGy . cm2 and an effective-dose of 9.8 Sv. 
Within 12 days of follow-up, patient developed an erythematous lesion in the 
lower back/sacral area, associated with skin edema and pigmentation, characterizing 
radiodermitis. Related symptoms included local pain and pruritus. Local treatment with 
an urea-based lotion, thrice a day for 15 days (Ureadin. Laboratorios Isdin. Barcelona, 
Spain) was initiated with progressive improvement of lesion aspect and 
symptomatology, and after 60 days there was just a small area of skin atrophy (figure 
3). Regarding LUTS, an important improvement was observed since the first month of 
follow-up, characterized by reduction of IPSS and QoL scores. Within 3 months, 
miccional interval was > 3 hours and there was a complete resolution of nycturia and 
miccional urgency. There was no recurrence of LUTS so far. 
DISCUSSION 
For several reasons, PAE for BPH can be a technically challenging procedure, 
leading to excessively radiation exposure for both patient and performing 
interventionists. Atherosclerosis and other anatomical features seem to be especially 
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4important, since identifying and catheterizing target arterial branches are among the 
most technical and time-consuming steps. Multiple different origins of the IVA and its 
prostatic branches had been described, including the anterior trunk of internal iliac 
artery, obturatory, internal pudendal arteries and others (6), and its identification can 
be somewhat difficult. Besides, pelvic arterial supply is markedly interconnected by 
anastomosis, some of them of clinical interest, as in several cases embolization can lead 
to non-target organ ischemia. 
Long procedure and fluoroscopy times are described for PAE, which can be 
explained the inherent challenge of the procedure, learning curve and rigorous 
protocols used by researchers. In one recent study including 34 PAE patients with 
prostates exceeding 90g (7), procedures lasted 95 to 295 minutes, with a mean of 158 
minutes, and fluoroscopy time varied from 19 to 143 minutes, mean of 55.4 minutes. In 
a work from Pisco et al. (3), PAE was performed in a mean procedure time of 72 
minutes and a mean fluoroscopy time of 18 minutes, which is somewhat lower than 
other published data. In this study, some of the patients were excluded due to 
atherosclerotic changes seen in pre-procedure AngioCT or AngioMRI, which probably 
collaborate to reduce those figures. Considering other procedures involving pelvic 
embolization, several studies addressing radiation dose during uterine artery 
embolization (UAE) were published in the last two decades (8). In most of them, values 
observed were considerable lower comparing to PAE data, fact that can probably be 
explained by anatomical aspects (i.e. vessels size) and atherosclerotic changes seen in 
the elderly population, as UAE patients are usually younger. Overall, the radiation 
exposure in the presented case was higher than mean values for both PAE and UAE 
published series. 
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5Several factors contributed for the major radiation exposure seen in this case, 
particularly. Older age and obesity had lead to diffuse arterial degeneration 
characterized by atherosclerotic changes, making catheterization and distal progression 
more difficult than usual (figure 1). Moreover, an important anastomosis connecting the 
left inferior vesical artery and an internal pudendal branch was identified and needed 
selective coiling in order to avoid non-target embolization (figure 2). Obesity itself also 
played an important role: in a digital C-arm, as patient thickness increases, the input 
dose of radiation required for sufficient penetration increases in an exponential manner 
(automatic kV increase). Image quality also deteriorates because of the generation of 
more scattered radiation (9). In this particular case, we have estimated a 2-3x increase 
of radiation exposure due to patient’s obesity. Finally, this case was performed during a 
teaching session, following the previously described “perfected technique” (4), in which 
embolization of prostatic branches involves a bilateral two-step approach. After the 
usual embolization from the prostatic artery, the microcatheter is pushed distally into 
the intraprostatic branches in order to continue embolization, avoiding this way any 
kind of early occlusion of target arteries and possibly leading to better clinical outcomes 
(4,5). All those aspects worked together increasing overall radiation exposure and 
leading to radiodermitis seen in this case. 
To avoid radiation injuries, any available dose-reducing features such as low-
dose fluoroscopy mode, pulsed fluoroscopy, collimation, and image-hold capabilities 
should be used. Reducing the number of DSA runs also plays a major role, once it 
corresponds to approximately 70% of the total radiation dose in interventional 
procedures. Moreover, adequate procedure planning using all available information is 
also crucial (9,10). In selected cases, a 3D-angiography performed from the internal iliac 
artery can be of special value helping to individualize the IVA itself and its origin, 
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6avoiding DSA series in multiple angulations. Society of Interventional Radiology 
guidelines for patient radiation dose management (9) recommends specific clinical 
follow-up of patients who received significant dose of radiation, being the suggested 
thresholds 3000 mGy for peak skin dose and 500 mGy . cm2 for Kerma-area-product. In 
fact, a single-site acute skin dose of 2000 mGy can lead to transient erythema and 
epilation, besides the risk for other stochastic injuries that cannot be predicted. 
Fluoroscopy time can be used as an indirect indicator of radiation dose, and values 
grater than 60 min should also trigger specific follow-up. 
Adequate material selection is also important, and considering the small size of 
target arteries and the eventual tortuosity, we believe 2.4 Fr or smaller microcatheters 
and a high-torque 0.014”or 0.016” guidewires would be useful for distal catheterization. 
Regarding selective embolization of anastomosis, those that involve bladder, rectum 
and penis are of particular importance. Probably, migration of small amounts of 
microspheres through anastomosis involving obturatory territory or other pelvic 
parietal structures will not lead to a clinical relevant complication; therefore, usually 
there is no need for coiling those connections, saving fluoroscopy time. The same way, 
particle reflux to seminal vesicle branches does not seem to cause major complications. 
Overall, knowledge of pelvic arterial anatomy, strict application of methods of 
radiation reduction and familiarity with advanced microcatheterization techniques are 
fundamental to decrease radiation exposure in PAE procedures and to avoid potential 
related complications. 
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FIGURES 
Figure 1. Radiodermitis lesion aspect within 12-days (A), 30-days (B) and 60-days (C) 
after PAE. 
Figure 2. (A) Ipsilateral oblique DSA demonstrating IVA origin in the proximal segment 
of the obturator artery (arrow). Note tortuosity due to atherosclerosis (*) difficulting 
distal catheterization. (B) Posterior-anterior DSA showing right prostatic lobe 
parenquimatous blush just below Foley catheter balloon (F). 
Figure 3. (A) DSA after selective catheterization of distal right IVA showing an 
important anastomosis connecting prostatic and pudendal territories (arrow). (B) A 
slightly later phase demonstrating prostatic parenquimatous blush (*) and also corpus 
cavernous blush (arrow). (C) After selective catheterization of the anastomosis, 
embolization was performed with a platinum microcoil (arrow). (D) Control DSA 
showing successful embolization of the shunt. 
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